What is Xenter?
Founded in 2020 by industry veteran Richard J. Linder, Xenter operates at the nexus of medical device innovation, data infrastructure, and clinical artificial intelligence. The company is defining a new category of Physical Intelligence, which serves as a scalable intelligence layer for modern healthcare systems. By capturing and analyzing real-time, high-fidelity data during clinical procedures, Xenter provides a comprehensive platform that connects disparate data points across the continuum of care. Headquartered in Draper, Utah, the firm is dedicated to empowering providers, patients, and health systems with actionable insights that improve diagnostic accuracy and procedural outcomes. Its platform is designed to evolve with every clinical interaction, creating a self-optimizing library of procedural data that drives future innovation in the life sciences sector.
How much funding has Xenter raised?
Xenter has raised a total of $73M across 3 funding rounds:
Seed
$2.8M
Series A
$12M
Series B
$58.3M
Seed (2021): $2.8M, investors not publicly disclosed
Series A (2021): $12M, investors not publicly disclosed
Series B (2026): $58.3M, investors not publicly disclosed
Key Investors in Xenter
Undisclosed Investor
An undisclosed institutional partner providing strategic capital to support the scaling of high-growth medical technology enterprises.
Undisclosed Investor
A private investment firm focused on backing disruptive innovations within the life sciences and healthcare infrastructure sectors.
Undisclosed Investor
An undisclosed entity specializing in long-term investments for companies developing advanced clinical intelligence and diagnostic platforms.
What's next for Xenter?
With the successful completion of this major enterprise-level funding round, Xenter is poised to scale its Physical Intelligence platform across broader clinical environments. The strategic deployment of this capital will likely focus on expanding the company's data infrastructure capabilities and deepening its integration within existing health systems. As the firm transitions from its initial development phase into a period of rapid commercial scaling, the focus will remain on enhancing the interoperability of its medical devices and refining its AI-driven diagnostic tools. By leveraging its growing repository of clinical data, Xenter aims to set a new standard for intelligent, connected healthcare, ultimately reducing the friction between data collection and clinical decision-making. The company's trajectory suggests a sustained commitment to long-term value creation in the digital health landscape.
See full Xenter company page
